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Laccifer lacca (Kerr) (LL) has widely been used as pigmenting, dying and coloring agent in chemical industry. 
Although, it has wide range of industrial applications, but unfortunately, due to lesser availability of data, it has been 
ignored. Keeping in mind, the broad application of Laccifer lacca (Kerr), we tried to report the in vitro anti-cancer effects 
along with its chemical characterization. This work is divided into two sections, first section to assess the anti-cancer 
activity of dye of Laccifer lacca (Kerr) employing SRB assay. In second section, the active fraction was processed to isolate 
the active chemical entities using preparative gradient HPLC-UV. The detector was set at 275 nm and 360 nm as reference 
wavelength. Results of ethyl acetate fraction (EA) showed promising anti-cancer spectrum for MDA-MB-231 (<10 µg/mL) 
and SiHa (<10 µg/mL) cell lines. Furthermore, laccaic acid-A was identified from EA of Laccifer lacca. In conclusion, our 
results suggested being the first report for isolation of laccaic acid-A from Laccifer lacca. We characterized the isolated 
compound be UV, IR, NMR and Mass spectrometry. We also propose that this is the first report for isolation of laccaic acid-
A using preparative HPLC with a good yield and purity. 
Keywords: Laccaic acid-A, Laccifer lacca, MDA-MB-231, Preparative HPLC, SiHa 
IPC Code: Int. Cl.19: C23C 22/27, A61K 8/02, A61K 38/00, A61Q 9/02 
Lac is a minute crawling insect mostly found in 
Southeast Asia and India. It is known by different 
names in different parts of world, i.e., Laccifer lacca 
and Kerria Lac. Traditionally, lac has a wide range of 
applications in different industry like coloring textiles 
and carpets. In reference to Vedas (ancient religious 
texts written in India between about 1500 and 1000 
BCE) and Sanskrit, lac was a good source of income 
for the people of India. Lac dye was been traded from 
Southeast Asia to eastern Iran and has been used to 
fabricate historical textiles and carpets till eighth or 
ninth century1. The major chemical constituents of lac 
are resin, dye and wax. The stick lac harvested from lac 
crop contains proteins, sand, soluble salts, sugar, 
woody matter, insect body debris, etc. Laccaic acids 
are the combination of anthraquinone derivatives 
present in lac dye. The wax portion has long chain 
esters, alcohols and hydrocarbons. The composition 
depends on the strain of insect, host plant and 
environmental conditions2. There are different types of 
laccaic acid ranging from laccaic acid A-F with limited 
application. Chromatographic techniques such column 
(cellulose) and preparative paper chromatography were 
used to isolate laccaic acid-A. IR and UV-Vis3 were 
used to characterize laccaic acid-A. The reported pKa 
value of laccaic acid was 4.4 and 6.54. Minor fraction 
of laccaic acid-B was isolated using a polyamide 
column. Structural determination of laccaic acid-B, its 
methylated product and xantholaccaic acid-B have 
been deduced with the help of NMR data. Chelated 
quinine group present in laccaic acid-B5 was reported 
by the researchers. Cellulose column was used to 
isolate laccaic acid-C as a major fraction whereas 
minor fraction is of laccaic acid-E. Both laccaic acid-C 
and laccaic acid-E are having same properties like that 
of laccaic acid-A and B but the only difference is the 
presence of aside chain (α- amino acid)6. Isolation of 
laccaic acid-D was performed by silica gel column and 
the mobile phase used was acetone7. Chromatographic 
technique such as high-speed counter-current was used 
to isolate laccaic acids-A, B, C and E8 from lac extract, 
that are the major chromophoric groups of lac-dye. 
Laccaic acids main components of lac dye have been 
identified using ESI LC/MS/MS comprising of a 
volatile mobile phase acetylacetone9. Toxicity studies 
of lac color were performed by developing an 
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analytical method to find the traces of lac dye present 
in diet feed to rats and feces of rats10. For the first time, 
High performance liquid chromatography-Diode array 
detector (HPLC-DAD) database was developed for the 
two species of lac dye, Kerria and Paratachardina 
genera, with the help of the Principal Component 
Analysis (PCA) and the statistical analysis11. Recently 
lac dye has proven its biological activity as it has a 
similar structure with the anti-cancer drug adriamycin 
(ADR) as both are anthraquinone derivatives. 
Antioxidant activity was investigated by DPPH assay, 
reducing power assay and the thiocyanate assay 
methods for laccaic acids and its aluminum lake12. 
Food coloring is mainly done by lac dye. Auto 
activations of the PHBP (Plasma Hyaluronan-Binding 
Protein) proenzyme (IC50=0.35–0.55 g/mL) and the 
catalytic activity of the active enzyme (IC50=1.1 g/mL) 
were due to protease inhibition property of lac dye13. 
Laccaic acids are also having a potent anti-cancer 
activity where it inhibits direct DNA competitive 
inhibitor of DNA methyl transferase I. In vitro 
methylation assay and alters the expression of 
methylated genes in MCF-7 breast cancer cells 
synergistically with 5-aza-2’deoxycytidine14. Recent 
literature survey reveals a comparison between 
Paratachardina and Kerria genera, the resinous 
exudation of lac dye using HPLC-DAD-MS for the 
identification of laccaic acid-A, B, C and E15. 
However, there is no report available till date for the 
complete identification and characterization of laccaic 
acid-A. Moreover, in order to evaluate its biological 
activity in broader spectrum, we have undertaken other 
cancer cell lines such as ZR-75-1, BT474, MDA-MB-
468 and many others (total fifteen). In this paper, we 
report for the first time the anti-cancer potential of 
laccaic acid-A on two different cancer cell lines along 
with the isolation and characterization of the same with 
elaborate spectroscopic characterizations. We are 
hopeful that this can be utilized as a standard data set 
for characterization of laccaic acid-A isolated from 
other natural or synthetic sources in future. In addition, 
the biological activity investigation may help in the 
future development of drugs which may result in 
unlocking the new anti-cancer agents from this dye. 
 
Methodology 
Chemicals and reagents 
Analytical grade reagents and chemicals were used 
for the study. Milli Q water was used for the study 
obtained from Milli Q water purification system 
(Millipore, Milford, MA, USA), methanol (Fisher 
Scientific, Loughborough, Leicestershire, UK) of 
HPLC grade, HPLC grade acetonitrile (Ranchem), 
perchloric acid, petroleum ether (60ºC-80ºC), 
chloroform and ethyl acetate AR Grade (Ranchem). 
Syringe filter of 0.22 µm and were procured from 
Merck, Mumbai. Lac-dye was provided from the 
IINRG (Indian Institute of Natural Resins and Gums), 
Ranchi, Jharkhand, India. RPMI 1640, fetal bovine 
serum (FBS), L-glutamine, dimethyl sulfoxide 
(DMSO), trichloroacetic acid (TCA), acetic acid, 
Sulforhodamine B (SRB) deuterated dimethyl 
sulfoxide (DMSO-d6) were purchased from Sigma 
(St. Louis, MO, USA). 
 
Preparation of Technical grade and sample preparation of lac dye 
Technical grade 
Wash the stick lac with water, acidify it 
(hydrochloric acid 0.1% on the volume of water) then 
the precipitate was allowed to settle down, collect the 
supernatant liquor by filtration. The mixed filtrate was 
treated with quicklime or calcium carbonate till 
colorless liquor appears. Salt of calcium lac dye 
which has separated out by filtration was effectively 
collected and repeatedly washed with water. The cold 
suspension (calcium salt of lac dye) in water was 
acidified and left for 07 days at room temperature till 
the dye crystallizes16,17. After this it was washed 
properly then filtered and finally dried (the yield 
obtained was 0.5% mass of stick lac). The quality and 
the quantity of the dye depend on the age of stick lac 
but it is nearly 80-90%18. The above technical grade 
lac dye was prepared according to the method 
described by Dey and Ghosh, 201819. 
 
Sample Preparation 
Lac dye of technical grade was obtained in powder 
form. Further, this lac was again subjected to 
fractionation. Fractionation was performed according 
to the polarity of the solvents, non-polar to polar 
solvents. The sample preparation methodology was 
followed from the previously reported method of Dey 
and Ghosh, 201819. At first 5 g of lac was taken in a 
50 mL volumetric flask containing 50 mL of 
petroleum ether (60ºC-80ºC) and allowed to 
ultrasonicate for 10 min at a temperature of 40°C. 
Petroleum ether solution containing lac was then 
transferred to 15 mL centrifuge tube, equally 
distributed in 5 centrifuge tubes, centrifuged for  
10 min at 5000 rpm. The clear supernatant liquid was 
collected in petri-dishes and allowed to evaporate. 
The lac dye which has settled down after 
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centrifugation in the centrifuge tubes were collected 
and dissolved in 50 mL volumetric flask containing 
chloroform. Further, the solution was subjected to 
ultrasonication for 10 min at a temperature of 40°C. 
Similarly, this procedure was repeated for ethyl 
acetate and water for the preparation of ethyl acetate 
and the water fraction. Thus, total 03 sets of fractions 
were prepared, chloroform (C), ethyl acetate (EA) and 
water (W) respectively. Fractionation with petroleum 
ether was mainly done for the defatting purpose to 
remove the unwanted oils and the unsaturated fatty 
acids from the samples.  
 
Cell viability assay 
Cell culture 
Anti-cancer activity of 03 fractions of lac dye were 
evaluated in 15 different cell lines established from 
the human breast cancer cell line (MCF-7, ZR-75-1, 
BT474, MDA-MB-468 and MDA-MB-231), human 
cervical cancer cell line (ME-180, SiHa and HeLa), 
human ovarian cancer cell line (A2780, OVCAR-3, 
PA-1, SK-OV-3 and NCI/ADR-RES) and human 
prostrate cancer cell line (DO145 and PC-3). The 
RPMI 1640 medium containing 2 mM L-glutamine 
and 10% fetal bovine serum was used to grow the cell 
lines. Plate density depends upon the doubling time of 
individual cells which were inoculated in a 96 well 
microtiter plates in100 µL. After the cells were 
inoculated the microtiter plates were placed in an 
incubator at 37°C, 5% CO2, 95% air and 100% 
humidity for a period of 24 h prior to addition of  
03 different fractions20, 21. 
 
Sample preparation 
The 03 different dried fractions were dissolved in 
dimethyl sulfoxide at a concentration of 100 mg/mL 
further dilution was made with water to 1 mg/mL and 
stored frozen before it was used. Aliquot of the frozen 
concentration of 1 mg/mL was thawed at the time of 
addition of different fractions and further diluted to 
800 μg/mL, 400 μg/mL, 200 μg/mL and 100 μg/mL 
with complete medium containing test article. The 
final drug concentrations were made to 80 μg/mL,  
40 μg/mL, 20 μg/mL and 10 μg/mL by the addition of 
10 µL from the above drug dilutions to the appropriate 
microtiter wells containing 90 µL of the medium. 
 
SRB (Sulforhodamine B) assay procedure 
The plates were incubated at standard conditions 
for a period of 48 h after the addition of samples lastly 
addition of cold TCA marks the termination of the 
assay. The cells were fixed under in situ conditions to 
which 50 µL of cold 30% (w/v) TCA (final 
concentration, 10% TCA) was added and incubated 
for a period of 60 min at about 4°C. Discard the 
supernatant and the plates were washed repeatedly  
5 times thoroughly by tap water and finally air dried. 
To each well add 50 µL of sulforhodamine B solution 
of 0.4% (w/v) in 1% acetic acid. Then the plates were 
incubated for 20 min at room temperature. Finally, 
after staining the unbound dye was recuperated 
followed by elimination of remnants of dye by 
washing with 1% acetic acid for 05 times. The plates 
were air dried. Elute the bound stain with 10 mM 
trizma base. At a wavelength of 540 nm with 690 nm 
reference wavelength the absorbance was taken on a 
plate reader. The concentration that inhibits cell 
growth by 50% (IC50) was found. Adriamycin (ADR) 
was used as a standard antitumor drug. At each  
drug concentration levels, the percentage growth  
was calculated20,21. The inhibitory concentration was 
calculated as: 
 
IC50=[Ti/C]x100% 
 
Where, the test growth in presence of the drug at the 
four concentration levels (Ti), control growth (C) and 
time zero (Tz)  
 
Chromatographic conditions and instruments 
Preparative HPLC 
The instrument used was Preparative HPLC (Prep-
HPLC) of Agilent 1100 series (Germany) with a 
binary pump system, having UV, VIS detector along 
with a fraction collector at the bottom. The column 
used was Agilent reverse-phase C18 column  
(250 mm×30 mm×10 µm) the detector was set at 275 
nm and reference at 360 nm wavelength. Data were 
acquired on Agilent Chemstation (Agilent Pvt. Ltd, 
Germany). The mobile phase consists of methanol: 
acetonitrile (85:15) as solvent system A and solvent 
system B consists of 0.15% perchloric acid in water. 
Finally, the mobile phases were filtered through a 
0.22 µm membrane filter. The flow rate was set at  
15 mL/min and the runtime was 33 min followed by 
gradient run. The fraction collector was set in a time 
base operation, i.e., time set for each vial was  
0.41 min and the maximum amount a vial can collect 
was 5 mL. After the fraction collection, the solvents 
were evaporated by rota evaporator (Buchi, Germany) 
then lyophilized and the dried compound was stored 
at 4ºC for further use.  
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Characterization studies: UV-VIS, IR, NMR, MS 
The study was performed in UV-VIS double beam 
spectrophotometer (model UV-1800, Shimadzu 
Limited) with 1 cm matched pair quartz cell. The EA 
isolated compound from Prep-HPLC was analyzed 
using Fourier transform infrared spectrometer (FTIR-
8400 S, Shimadzu, Japan). Mass spectrometry of EA 
isolated compound was performed in Thermo 
Scientific LTQ XL. EA isolated compound was 
subjected to 1H and 13C NMR, carried out at 400 
MHz, using Jeol NMR.  
 
Results  
Cytotoxic activity 
The cytotoxic activity was determined for water 
(W), ethyl acetate (EA) and chloroform (C) fraction 
against MCF-7, ZR-75-1, BT-474, MDA-MB-468, 
MDA-MB-231, ME-180, SiHa, HeLa, A2780, 
OVCAR-3, PA-1, SK-OV-3, NCI/ADR-RES, 
DO145 and PC-3 cancer cell lines, using SRB assay 
employing Adriamycin (ADR) as a reference drug. 
All the 03 fractions were tested in 15 cancer cell 
lines among which EA has promising activity 
against MDA-MB-231 and SiHa cancer cell lines 
with IC50 value below 10 µg/mL for EA fraction 
and ADR. At higher concentration, other fractions 
such as C and W fraction were also found to be 
active over these two cancer cell lines. Apart from 
these two cancer cell lines, all the fractions  
were found to be active on other cell lines too 
however having IC50 values as high as 80 µg/mL or 
above. These results have been summarized in 
Table 1-3 & Fig. 1-2. 
Chromatographic isolation of ethyl acetate fraction using 
Preparative HPLC 
The optimized chromatogram was observed 
through an effective gradient run. After the 
chromatographic run, 03 elution peaks were observed 
having retention time (Rt) 6.181, 16.749 and 27.625 
min respectively (Fig. 3). The peak having Rt 6.181 
min was of higher altitude or absorbance when 
compared to other peaks. The associated compound 
with Rt 6.181 was effectively collected in the fraction 
collector of vial no 20, 29, 38 and 47. Samples were 
collected till sufficient amount was recovered for 
further analysis. 
 
Identification and elucidation of EA fraction by UV-VIS, IR 
and MS 
The λmax of EA fraction was found to be 494.50 nm 
for the visible spectrum were as 289 nm in the 
ultraviolet spectrum (Fig. 4). Laccaic acid-A in the 
visible spectrum is reported to have maximum 
absorbance at 497 nm and 287 nm for the ultraviolet 
region3. In IR spectrum the EA fraction showed 
carbonyl stretching at 1710.92 cm-1. The peak was 
assigned to a carboxylic acid group, while 1620.26 
cm-1 peak was assigned for 1, 4-quinone where both 
carbonyl groups have been chelated by a total of 02 or 
03 perihydroxyl groups. The 1670.41cm-1 peak was 
assigned for –C=O amide stretch, 3356.25 cm-1 peak 
was attributed to –OH group, whereas 2924.18 and 
2854.74 cm-1 were assigned for alkane stretching (-
CH2-CH2-) (Fig. 5). The MS result showed molecular 
ion peak of m/z 536.09 [M-H] - (Fig. 6) which is 
comparable to laccaic acid-A having a molecular 
Table 1 — IC50a (µg/mL) of Lac dye fractions obtained from Laccifer lacca tested on cell lines 
Cell lines Chloroform Fraction Ethyl acetate Fraction Water Fraction Adriamycin 
MCF-7  >80 >80 >80 <10 
ZR-75-1  NE* NE* NE* <10 
BT474  >80 >80 >80 <10 
MDA-MB-468  >80 >80 >80 <10 
MDA-MB-231  37.9 <10 60.1 <10 
ME-180  NE* NE* NE* <10 
SiHa 79.2 <10 57.0 <10 
HeLa  >80 >80 >80 <10 
A2780  NE* NE* NE* <10 
OVCAR-3  NE* NE* NE* <10 
PA-1  NE* NE* NE* <10 
SK-OV-3  >80 >80 >80 <10 
NCI/ADR-RES  NE* NE* NE* <10 
DU145  >80 >80 >80 <10 
PC-3  NE* NE* NE* <10 
aIC50: concentration of fraction required to reduce cell survival by 50%; aIC50 of ≤ 10 µg/mL is considered to demonstrate activity; 
NE*: Not Estimated 
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weight of 537 amu as reported earlier8,9. The base 
peak was found to be at 492.00 (m/z). We assume that 
the appearance of this peak has been due to the 
removal of one molecule of CO2 (molecular weight 
44) from the laccaic acid resulting in the peak at  
m/z 492.00 [M-H-CO2] -. 
 
 
 
Fig. 1 — Cytotoxicity assessment by SRB assay in MDA-MB-
231 (Human Breast Cancer Cell Line) compared to the reference 
drug. Water (W), Ethyl acetate (EA) and Chloroform (C) fraction; 
Adriamycin (ADR) 
Table 2 — Activity of Lac dye fractions against human breast cancer cell line MDA-MB-231 
 Human Breast Cancer Cell Line MDA-MB-231 
 % Control Growth 
  Drug Concentrations (µg/mL) 
 Experiment 1 Experiment 2 Experiment 3 Average Values 
 10 20 40 80 10 20 40 80 10 20 40 80 10 20 40 80 
C 63.1 43.9 43.6 41.4 68.3 63.3 44.8 52.7 51.8 46.1 37.9 43.8 61.1 51.1 42.1 46.0 
EA 46.8 39.4 44.2 46.5 57.2 40.5 39.3 48.2 43.7 40.3 34.8 44.3 49.2 40.1 39.4 46.4 
W 60.0 51.7 52.6 45.3 64.5 61.4 47.4 51.4 67.5 47.6 44.7 51.2 64.0 53.5 48.2 49.3 
ADR 29.9 39.5 37.6 22.8 43.7 32.3 41.3 40.2 33.8 21.8 28.8 41.5 35.8 31.2 35.9 34.8 
Water (W), Ethyl acetate (EA) and Chloroform (C) fraction; Adriamycin (ADR) 
 
Table 3 — Activity of Lac dye fractions against human cervical cancer cell line SiHa 
 Human Cervical Cancer Cell Line SiHa 
 % Control Growth 
 Drug Concentrations (µg/mL) 
 Experiment 1 Experiment 2 Experiment 3 Average Values 
 10 20 40 80 10 20 40 80 10 20 40 80 10 20 40 80 
C 44.8 57.1 45.8 33.5 65.5 56.7 50.1 62.0 70.0 59.6 62.4 57.1 60.1 57.8 52.8 50.9 
EA 35.8 29.6 31.3 32.7 59.6 58.0 49.9 49.0 50.3 42.9 38.5 48.7 48.6 43.5 39.9 43.5 
W 36.9 39.4 39.5 31.1 91.5 65.0 55.1 53.1 78.2 48.0 55.3 58.6 68.9 50.8 50.0 47.6 
ADR 49.5 48.0 39.0 40.2 46.6 46.6 55.4 54.9 26.0 24.2 32.0 43.3 40.7 39.6 42.1 46.1 
Water (W), Ethyl acetate (EA) and Chloroform (C) fraction; Adriamycin (ADR) 
 
 
Fig. 2 — Cytotoxicity assessment by SRB assay in SiHa (Human 
Cervical Cancer Cell Line) compared to the reference drug. 
Water (W), Ethyl acetate (EA) and Chloroform (C) fraction; 
Adriamycin (ADR) 
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2D NMR Spectroscopy 
The 1H and 13C NMR of isolated compound from 
ethyl acetate fraction using (CD3)2SO (Table 4 and 
Fig. 7 & Fig. 8). The HMQC (Fig. 9) of EA 
compound gives the interaction of carbon and 
hydrogen which are directly attached in the aromatic 
region that is δH 7.671 (H-8) to δC 114.691 (C-8); δH 
6.995 (H-4/) to δC 129.864 (C-4/); δH 6.846 (H-2/) to 
δC 131.915 (C-2/) and δH 6.778 (H-5/) to δC 115.922 
(C-5/) whereas in the aliphatic region the methylene 
attached to NH can be easily recognized δH 3.518  
(H-4//) to δC 63.021 (C-4//) giving an idea of 
molecular structure of EA. The DEPT-135 (Fig. 10) 
of EA compound shows that there are four aromatic 
carbons, i.e., CH appearing positive δC 131.843  
(C-2/), 129.697 (C-4/), 115.802 (C-5/) and 114.604  
(C-8). In the aliphatic region, i.e., CH2 appears 
negative δC 63.011 (C-4//), 34.847 (C-5//) and  
CH3 appearing positive δC 23.166 (C-1//) giving  
an idea of hybridization of carbon for the molecular 
structure of EA. The peaks appearing in the  
region δ 20.981, 66.250, and 14.503 were determined 
as solvent trace impurities for ethyl acetate22. The 
COSY (Fig. 11) of EA compound shows that there is 
a correlation between the two protons appearing at δ 
3.521 (H-4//) and 2.581 (H-5//) showing there is a 
spin-spin coupling between the two methylene groups 
(-CH2-CH2-).Thus the compound identified as laccaic 
acid-A (Fig. 12). 
 
 
Fig. 5 — IR spectra of ethyl acetate fraction of lac dye 
 
 
Fig. 6 — HR-ESI-MS of ethyl acetate isolated compound 
 
 
Fig. 3 — Chromatogram of Ethyl acetate fraction of lac dye by 
Prep-HPLC 
 
 
 
Fig. 4 — UV spectra of ethyl acetate fraction of lac dye 
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Discussion 
The present study describes the anti-cancer 
potential of ethyl acetate fraction of laccaic acids in 
02 different cancer cell lines for the first time. Ethyl 
acetate fraction of laccaic acids has shown anti-cancer 
activity in MDA-MB-231 (human breast cancer cell 
line) and SiHa (human cervical cancer cell line) 
cancer cell lines at a very minimum concentration 
below 10 µg/mL which is similar when compared to 
standard drug ADR. Previously from the literature, it 
has been reported that laccaic acid-A is having anti-
cancer activity in MCF-7 human breast cancer cell 
line14. The bioactive ethyl acetate fraction was then 
further processed to isolate the active compound, 
followed by characterization. The λmax was found to 
be 494.50 and 289 nm for the visible and ultraviolet 
region. In the visible region this position is the 
characteristic feature of anthraquinone with typical 
 03 peri-hydroxyl groups shows absorption maxima in 
the region of 480 to 510 nm, for example, Islandicin  
(2-methyl-1,4,5-trihydroxy), Helminthosporin  
(2-methyl-4,5,8-trihydroxy) and purpurin (1,2,4-
Trihydroxyanthraquinone) has an absorption maxima 
492 nm, 480 nm and 482 nm in the visible region3, 23 
showing 03 perihydroxyl groups attached to 
anthraquinone moiety. This shows that the EA 
fraction has the presence of anthraquinone ring 
Table 4 — 1H and 13C NMR data of EA compounds in DMSO-d6. 
Position δ H (J in Hz) δ C 
1  138.005 
2  148.642 
3  104.945 
4  154.008 
4a  111.806 
5  125.011 
6  119.127 
7  159.413 
8 7.665 (s, 1H) 114.604 
8a  136.165 
9  186.532 
9a  123.286 
10  183.121 
10a  120.354 
11 13.573 (s, 1H) 168.881 
12 13.153 (s, 1H) 167.271 
13 9.122 (s, OH, 1H)  
14 10.703(s, OH, 1H)  
15   
16   
17 5.270 (s, OH, 1H)  
1/  123.171 
2/ 6.847 (s, 1H) 131.853 
3/  130.032 
4/ 7.007 (d, 7.2, 1H) 129.649 
5/ 6.779 (m, 1H) 115.792 
6/  153.625 
1// 1.744 (s, 3H) 23.166 
2//  169.609 
3// 7.877 (s, 1H)  
4// 3.537 (t, 6.6, 2H) 63.011 
5// 2.596 (t, 7.6, 2H) 34.837 
CH3 (Ethyl Acetate) 1.944 (s) 20.981 
CH2CH3 (Ethyl Acetate) 4.007 (q)  
CH2CH3 (Ethyl Acetate) 1.18 (t)  
CH2 (Ethyl Acetate)  66.250 
CH3 (Ethyl Acetate)  14.503 
 
 
Fig. 7 — 1H-NMR spectrum of ethyl acetate isolated compound 
(400 MHz – DMSO-d6) 
 
 
Fig. 8 — 13C-NMR spectrum of ethyl acetate isolated compound 
(400 MHz – DMSO-d6) 
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system with 03 perihydroxyl groups. Moreover, this 
anthraquinone system shows multiple bands between 
260 nm and 300 nm23 which is another characteristic 
feature of the anthraquinone ring system. The IR of 
EA fraction shows bands in the region of carbonyl 
stretching at 1710.92, 1670.41 and 1620.26 cm-1. 
Literature review reveals our findings for the IR 
spectroscopy that the bands are present in the region 
of carbonyl stretching at 1715, 1677, and 1620 cm-1 
for the laccaic acid-A3. The molecular mass of the EA 
fraction was found to be 537.09 amu. The molecular 
ion peak was found to be 536.09 [M-H]- and the base 
peak was found to be 492.00 [M-H-CO2]- due to the 
removal of one molecule of CO2, the mass 
spectrometry data was fully supported by the 
literature8,9. For the first time, the NMR data for 
laccaic acid A has been reported in this paper. 
Previously from the literature, it was found that only 
1H NMR data has been reported that too by using tau 
(τ) value4. In this paper, for the first time, we are 
reporting the 1H and 13C of laccaic acid-A in delta (δ) 
value along with HMQC, DEPT-135 and COSY 
which provides the structural conformation of the 
isolated compound as laccaic acid-A having anti-
cancer potential. 
 
Conclusion 
In conclusion, the compound laccaic acid-A (7-
acetyl-6-ethyl-3,5,8-trihydroxy-9,10-dioxoanthracene-
1,2-dicarboxylic acid) was isolated for the first time 
using preparative HPLC from Laccifer lacca (Kerr) 
crude ethyl acetate fraction and characterized by UV, 
IR, MS and NMR. This isolated compound laccaic 
acid-A has proven to be an anticancer agent in MDA-
MB-231 (human breast cancer cell line) and SiHa 
(human cervical cancer cell line) cancer cell lines for 
the first time. These new findings can contribute in 
 
Fig. 9 — HMQC-NMR spectrum of ethyl acetate isolated 
compound 
 
 
Fig. 10 — DEPT-135-NMR spectrum of ethyl acetate isolated 
compound 
 
 
Fig. 11 — COSY-NMR spectrum of ethyl acetate isolated 
compound 
 
 
 
Fig. 12 — Chemical structure of laccaic acid A 
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developing a new anticancer drug which can open the 
gateway for the treatment of cancer from this dye. 
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